Ethnic Patterns in Early Onset Multimorbidity Emerge Early and Travel with Deprivation
A large UK analysis of early onset multimorbidity has separated a broad clinical problem into distinct ethnic patterns, each carrying different burdens of service use, prescribing, mortality, and years of life lost. The study used linked primary and secondary care data from the Clinical Practice Research Datalink GOLD and focused on people aged 16 to 39 years when their second long-term condition was recorded. That age window matters clinically: by the time a second chronic condition appears in early adulthood, the trajectory is already moving away from isolated disease and toward cumulative disability, repeated contact with healthcare, and earlier death.
Investigators examined 837,869 people with early onset multimorbidity. White participants made up the largest group at 777,906, or 93% of the cohort, while 33,915 people were South Asian and 26,048 were Black African/Caribbean. Across 204 long-term conditions, latent class analysis identified four multimorbidity clusters in White groups and three clusters each in South Asian and Black groups. The clustering approach is clinically important because it captures co-occurring conditions as they exist in real practice, where hypertension, depression, chronic pain, and other long-term illnesses rarely arrive one at a time.
Early onset multimorbidity was more common among South Asian and Black adults than among White adults. The prevalence reached 59% in South Asian participants and 56% in Black participants, compared with 42% in White participants. Those differences do not stand alone as epidemiologic curiosities; they reflect a pattern of earlier accumulation of chronic disease in populations already exposed to socioeconomic disadvantage. Among South Asian and Black groups, deprivation was consistently higher across all multimorbidity clusters, creating a gradient that ran through the entire analysis rather than concentrating in a single phenotype.
Distinct Clusters Shared Core Conditions but Not the Same Clinical Weight
Some conditions appeared across all ethnic groups. Hypertension, depression, and painful conditions formed part of the common clinical ground, which is a reminder that cardiometabolic disease, mental health, and chronic pain often travel together long before a patient reaches middle age. Yet each ethnic group also showed its own exclusive long-term conditions and a different sociodemographic mix, suggesting that the same label of multimorbidity can conceal very different clinical realities.
In White participants, the cluster with the highest rates and odds of adverse outcomes was predominantly male, with 54% men among 44,150 individuals, and it was more socioeconomically deprived than the cluster with the lowest rates and odds of outcomes. In South Asian and Black groups, deprivation was more uniformly elevated across clusters, rather than separating neatly into high- and low-risk pockets. This pattern suggests that social risk may be more deeply embedded across the full distribution of disease in minoritised ethnic groups, rather than being confined to a single subgroup.
One cluster in each ethnic group stood out for heavier use of healthcare and worse outcomes. Primary care consultations, hospitalisations, long-term prescribing, and mortality all rose together in those higher-risk clusters. The clinical signal is straightforward: multimorbidity in early adulthood is not just a list of diagnoses. It is a marker of repeated healthcare dependence, medication burden, and rising probability of premature death.
Mortality Was Lower in Proportion, Yet Earlier and More Costly in Lost Life Years
By the end of follow-up, 4% of White participants with early onset multimorbidity had died, compared with 2% of South Asian and Black participants. The crude death proportion looks lower in the latter groups, but the age at death told a different story. South Asian and Black participants died younger and lost more years of life. For clinicians, that gap between death proportion and life-years lost is decisive. A lower percentage of deaths does not mean a lighter burden when death arrives earlier in the life course.
This is where the biology of chronic disease and the sociology of access intersect. Earlier onset means a longer period for cardiovascular injury, psychiatric illness, pain syndromes, and polypharmacy to compound each other. It also means a longer period in which repeated contact with services can be both a marker of severity and a response to inadequate upstream prevention. The study’s data on prescribing and consultations fit that pattern: the heaviest-utilization clusters were the same clusters carrying the greatest mortality burden.
The results also show why life expectancy measures deserve as much attention as mortality counts. Years of life lost capture the fact that two groups can have different death proportions but very different losses in potential lifespan. In practical terms, a young adult with multimorbidity who dies at 40 contributes a very different burden than an older adult who dies much later, even if the raw death count appears smaller.
What Primary Care and Equity Policy Need to Read Into the Data
The study points directly to earlier identification and earlier intervention. Clinicians working in primary care and community settings are likely to encounter the first signs of this pattern through repeated consultations, escalating prescribing, and the gradual layering of physical and mental health conditions. The data argue for a life-course approach rather than a single-disease model, especially in socioeconomically deprived communities where chronic illness accumulates early and more densely.
For health systems, the message is also operational. Multimorbidity clusters were not evenly distributed, and the outcome burden was not uniform across ethnicity or deprivation. Service planning that treats early multimorbidity as a single entity will miss the clusters with the greatest need for structured review, medication rationalisation, mental health support, pain management, and cardiovascular risk control. A young adult presenting with hypertension, depression, and painful conditions is already on a different trajectory than someone with one isolated diagnosis.
The study has clear limitations. Ethnicity data were missing for some individuals, age of diagnosis did not always reflect the true age of onset, and people from Mixed, Chinese, and other ethnic groups were excluded because the sample size was too small for reliable analysis. Even with those constraints, the scale of the cohort and the consistency of the deprivation gradient make the findings difficult to dismiss.
The central clinical message is not subtle: early onset multimorbidity is common, socially patterned, and linked to earlier death and greater loss of life in South Asian and Black populations. The unresolved task is not whether these disparities exist. It is how early in life healthcare systems are willing to intervene, and whether those interventions will be matched to the clusters where disease, deprivation, and premature mortality converge.